Search


Search Parameters








1 - 18 of 18 items
Clinical trials in Latin America: implications for the sustainability and safety of pharmaceutical markets and the wellbeing of research subjects Open Access
Núria Homedes, Antonio Ugalde

Four words regarding clinical trials: science/profit, risks/benefits Open Access
Antonio Ugalde, Núria Homedes

Pills for profits. The transformation of the pharmaceutical industry Open Access
Antonio Ugalde, Núria Homedes

The sustainability of the health system and the pharmaceutical market: A permanent interaction between the cost of medications, the patent system, and disease care Open Access
Tomás Gómez Franco, Eva Matarín Rodríguez-Peral, Francisco García García

Scientific advances and moral progress: the end does not justify the means Open Access
Juan Carlos Tealdi

Bioethical problems in researching new vaccines: Do they respond to public health reasons? Open Access
Juan Carlos Tealdi

The medication cycle: its impact on access to and adequate use of drugs Open Access
Homedes Núria, Ugalde Antonio

Authors' response Open Access
Ugalde Antonio, Núria Homedes

Four other keywords to critically analyze a clinical trial: hypothesis, implementation, analysis and publication Open Access
Teresa Forcades i Vila

Clinical trials, the State and society: where does science end and profit-making begin? Open Access
Cláudio Lorenzo, Volnei Garrafa

Questioning clinical trials Open Access
Ricardo Alberto Martínez

Clinical research in Latin America and Argentina: time for a change? Open Access
Daniel Ferrante

Toward independent clinical trials in Latin America. Comments on "Four words regarding clinical trials" Open Access
Carlos Daniel Tajer

The precautionary principle in biomedical research, safety, post-research obligations and alleged therapeutic efficacy of experimental drugs: Violations of patient dignity Open Access
Sergio Eduardo Gonorazky

Globalization and medical identities in clinical trials Open Access
Medardo Ávila Vázquez

Two more words regarding clinical trials: deception/truth, the moral anemia of Big Pharma Open Access
Marvin Gómez-Vargas

Medicinal cannabis: beyond the myth, just another (herbal) drug Open Access
Paulo Cáceres Guido

Commentary on the article “Bioethical problems in researching new vaccines: Do they respond to public health reasons?” Open Access
Alejandro Ellis

1 - 18 of 18 items